Ativo Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-11,218
Closed -$404K – 228
2015
Q2
$404K Sell
11,218
-7,137
-39% -$261K 0.14% 186
2015
Q1
$557K Sell
18,355
-5,410
-23% -$140K 0.22% 106
2014
Q4
$471K Sell
23,765
-7
-0% -$157 0.19% 147
2014
Q3
$473K Sell
23,772
-2,200
-8% -$46.3K 0.19% 111
2014
Q2
$592K Sell
25,972
-8,617
-25% -$153K 0.26% 71
2014
Q1
$445K Sell
34,589
-4,111
-11% -$58.9K 0.18% 131
2013
Q4
$528K Sell
38,700
-4
-0% -$48 0.23% 92
2013
Q3
$429K Sell
38,704
-2,189
-5% -$21.8K 0.2% 113
2013
Q2
$337K Buy
+40,893
New +$343K 0.17% 140

Other funds holding RGEN

Ativo Capital Management's RGEN Position: Q3 2015 in Review

Ativo Capital Management sold out of Repligen (RGEN) in Q3 2015, closing a stake of 11,218 shares — an estimated $404K sold.

Ativo Capital Management first reported a position in RGEN in Q2 2013 and held it in 9 quarters. The position peaked at $592K in Q2 2014. 184 funds tracked by Wall St. Rank hold RGEN as of Q3 2015.

  • Ativo Capital Management reported no remaining Repligen position as of Q3 2015 after selling out during the quarter.
  • Ativo Capital Management sold 11,218 Repligen shares in Q3 2015, an estimated $404K.
  • Ativo Capital Management first reported a position in Repligen in Q2 2013 and held it in 9 quarters.
  • Ativo Capital Management's Repligen position peaked at $592K in Q2 2014.
  • 184 funds tracked by Wall St. Rank held Repligen as of Q3 2015.

Based on Ativo Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.